U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768319) titled 'The Effectiveness of Online Group Dialectical Behavioral Therapy on Bulimia Nervosa' on Aug. 11, 2022.
Brief Summary: Bulimia Nervosa (BN) is a kind of chronic refractory mental disorder with high prevalence and relapse rate, which would cause serious damage to physical and mental health. Dialectical Behavioral Therapy (DBT) is an internationally effective and evidence-based therapy for BN patients. Previous studies have found that DBT group therapy can significantly improve the core symptoms of BN patients. Our research group has conducted DBT group therapy for BN, and found that after 12 weeks of treatment, the frequencies of bing...